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The Hippo (Hpo) kinase cascade restricts tissue
growth by inactivating the transcriptional coactivator
Yorkie (Yki), which regulates the expression of target
genes such as the cell death inhibitor diap1 by un-
known mechanisms. Here we identify the TEAD/
TEF family protein Scalloped (Sd) as a DNA-binding
transcription factor that partners with Yki to mediate
the transcriptional output of the Hpo growth-regula-
tory pathway. The diap1 (th) locus harbors a minimal
Sd-binding Hpo Responsive Element (HRE) that me-
diates transcriptional regulation by the Hpo pathway.
Sd binds directly to Yki, and a Yki missense mutation
that abrogates Sd-Yki binding also inactivates Yki
function in vivo. We further demonstrate that sd is re-
quired for yki-induced tissue overgrowth and target
gene expression, and that sd activity is conserved
in itsmammalian homolog.Our results uncover a here-
tofore missing link in the Hpo signaling pathway
and provide a glimpse of the molecular events on a
Hpo-responsive enhancer element.
INTRODUCTION
The control of organ size is a fundamental aspect of multicellular
life that still remains poorly understood (Conlon and Raff, 1999).
In most metazoans, organ growth is accompanied by a net in-
crease in cell number, which in turn depends on the rate at which
cells are generated by proliferation, as well as the rate at which
they are eliminated by apoptosis. Coordination between these
two processes plays a critical role in attaining proper organ size
and maintaining tissue homeostasis in multicellular organisms.
Studies in recent years, primarily conducted in the fruit flyDro-
sophila, have implicated the Hippo (Hpo) signaling pathway as
a central mechanism that regulates organ size by controlling
both cell proliferation and cell death (Edgar, 2006; Pan, 2007;
Harvey and Tapon, 2007). This pathway is defined by a kinase
cascade whereby the Ste20-like kinase Hpo, facilitated by the
WW-domain-containing adaptor protein Salvador (Sav), phos-
phorylates and activates the NDR family kinase Warts (Wts)
(Wu et al., 2003). Wts, facilitated by the Mob family protein
Mats (Lai et al., 2005), phosphorylates the transcriptional coacti-388 Developmental Cell 14, 388–398, March 2008 ª2008 Elsevier Ivator Yorkie (Yki) (Huang et al., 2005) and inactivates Yki function
by excluding it from the nucleus (Dong et al., 2007). Inactivation
of the Hpo, Sav, or Wts tumor suppressors, or overexpression of
the Yki oncoprotein, results in massive tissue overgrowth char-
acterized by excessive cell proliferation and diminished apopto-
sis. Recent studies have also implicated the atypical cadherin Fat
(Silva et al., 2006; Willecke et al., 2006; Bennett and Harvey,
2006) and the membrane-associated FERM-domain proteins
Expanded (Ex) andMerlin (Mer) (Hamaratoglu et al., 2006) as up-
stream components of the Hpo pathway, although their precise
biochemical function with respect to the Hpo kinase cascade re-
mains to be determined (Cho et al., 2006; Feng and Irvine, 2007;
Maitra et al., 2006). The Hpo pathway has been reported to
antagonize the expression of a handful of target genes, such as
the cell cycle regulator cyclin E (cycE), the cell death inhibitor
diap1, and the microRNA bantam (Thompson and Cohen,
2006; Nolo et al., 2006), as well as ex andmer, as part of a nega-
tive feedback regulatory loop (Hamaratoglu et al., 2006).
Accumulating evidence suggests that the Hpo pathway plays
a conserved role in organ size control and tissue homeostasis in
mammals.NF2, the human counterpart ofmer, is a known tumor
suppressor gene whose mutations lead to neurofibromatosis
(McClatchey and Giovannini, 2005). YAP, the mammalian homo-
log of yki, is amplified in certain tumors and can transform im-
mortalized mammary epithelial cells in vitro (Overholtzer et al.,
2006) and accelerate tumorigenesis in conjunction with p53
loss and c-myc overexpression (Zender et al., 2006). Recently,
we and others demonstrated that the mammalian homologs
of Hpo (MST1/2), Sav (WW45), and Wts (Lats1/2) constitute an
analogous kinase cascade that inactivates YAP function via
a similar phosphorylation event (Dong et al., 2007; Zhao et al.,
2007). Moreover, conditional YAP overexpression leads to mas-
sive organomegaly (Dong et al., 2007; Camargo et al., 2007) and
rapid tumorigenesis (Dong et al., 2007), suggesting that the Hpo
pathway is a universal regulator of tissue homeostasis in meta-
zoan animals.
A major gap in our current understanding of the Hpo signaling
pathway concerns how Yki regulates the expression of the Hpo
pathway target genes. Like other transcriptional coactivators,
Yki does not bind to DNA directly, but instead functions by inter-
acting with, and stimulating the activity of, DNA-binding tran-
scription factors. Yki and its mammalian homolog YAP have
been reported to interact with several DNA-binding transcription
factors, including the p53 family member p73 (Strano et al.,
2001), the Runt family member PEBP2a (Yagi et al., 1999), andnc.
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Giot et al., 2003). However, it remains to be determined whether
any of these proteins, or any of the other unknown proteins, is the
relevant partner for Yki in the context of the Hpo growth-regula-
tory pathway. Furthermore, the available genetic data do not
distinguish whether the known Hpo pathway target genes are
regulated by Yki directly or indirectly through intermediary tran-
scription regulators that are themselves induced by Yki. Answers
to these questions require identification of Hpo-responsive reg-
ulatory regions in the known target genes.
Scalloped (Sd) is the only TEAD/TEF family DNA-binding tran-
scription factor in Drosophila (Campbell et al., 1992). Much of
what we know about Sd comes from studies in the Drosophila
wing, where Sd interacts with the Vestigial (Vg) protein to form
a transcription factor complex that promoteswing blade develop-
ment (Simmondset al., 1998;Halder et al., 1998). Vgdoesnot bind
DNAbut acts exclusively by binding to Sdand providing coactiva-
tor function for the Sd-Vg complex. Transcriptional targets of the
Sd-Vg complex include sd and vg themselves, and other genes
such as distalless (Simmonds et al., 1998; Halder et al., 1998; Liu
etal., 2000).sdand vgarebothexpressedand required for thesur-
vival of wing blade cells, and sd or vg clones fail to grow within
thewingblade, but grownormally in thewinghinge andnotum (Liu
et al., 2000; Kim et al., 1996). Despite these similarities, there is
a fundamental dichotomy between sd and vg—while vg is only
expressed in the wing imaginal disc (Williams et al., 1991), sd is
expressed in multiple tissues during embryonic and larval devel-
opment (Campbell et al., 1992), suggesting that Sd can partner
with non-Vg coactivators in tissues outside the wing blade. The
identity of sucha coactivator or coactivators is currently unknown.
In the current study, we identify the DNA-binding transcription
factor that partners with Yki to mediate the transcriptional output
of the Hpo pathway. First, we defined a minimal enhancer ele-
ment that confers Hpo-responsive regulation of a known Hpo
pathway target gene, and identified a sequence-specific tran-
scription factor that binds to this DNA element. Second, we de-
fined a functional domain within the Yki protein that mediates its
interaction with its DNA-binding partner, and identified a protein
that binds this domain. Both approaches converged to reveal Sd
as a DNA-binding factor that mediates the transcriptional output
of the Hpo pathway. sd is required for yki-induced tissue over-
growth and target gene expression, and the activity of sd is con-
served in its mammalian homolog. Our studies therefore uncover
an important missing link in the Hpo signaling pathway.
RESULTS
Dissection of the diap1 (th) Locus Reveals aMinimal Hpo
Responsive Element, or HRE
In order to gain a mechanistic understanding of how the Hpo
pathway regulates the expression of target genes,we first sought
to dissect the Hpo pathway-responsive regulatory elements of
a representational Hpo pathway target gene. Among the best-
studied Hpo pathway targets—cycE, diap1, and the microRNA
bantam—we focused on diap1 since its regulation by the Hpo
pathway is more robust and ubiquitous in the eye imaginal discs
than that of cycE (Wu et al., 2003; Huang et al., 2005), andmicro-
RNApromoters are lesswell defined than those of protein-coding
genes (Kim and Nam, 2006).DeThe diap1 gene contains a single coding exon, which can be
alternatively spliced with one of three possible upstream exons
to generate RA, RB, or RC transcript (Figure 1A), with RA being
the predominant form throughout all stages of Drosophila devel-
opment (Flybase: http://flybase.bio.indiana.edu/). To map the
enhancer element or elements within the diap1 gene that confer
Hpo-responsive transcriptional regulation, we cloned genomic
DNA fragments surrounding the diap1 locus upstream of the
hsp70 basal promoter and a lacZ reporter in an enhancer-detec-
tion P element vector (Wharton and Crews, 1993). Reporter
expression was examined in the eye imaginal discs to identify
the fragment that showed elevated lacZ expression in hpo
loss-of-function clones. Once a Hpo-responsive DNA fragment
was identified, it was further divided and tested to narrow
down the Hpo-responsive region. Interestingly, we found that
DNA sequence within the intron of the RA transcript (construct
2), but not DNA sequence 50 to the transcription start site (con-
struct 1), confers Hpo responsiveness (Figures 1B–1C0). After
three additional rounds of reiterative subdivision, we mapped
the Hpo-responsive region to an 300 bp fragment (construct
2B2C; Figures 1D and 1D0) within the intron of the RA transcript.
Inspection of the300bpHpo-responsive region revealed two
stretches of DNA sequences (36 bp and 32 bp) that are highly
conserved between D. melanogaster and D. pseudoobscura
(Figure 2A), two Drosophila species that diverged 25–55 million
years ago (Richards et al., 2005). Next, we cloned two copies of
each conserved DNA stretch into the enhancer-detection vector
and tested their ability to conferHpo responsiveness.While a lacZ
reporter driven by the 36 bp sequence (2B2C1)was unresponsive
to loss of hpo (Figures 2B and 2B0), a lacZ reporter driven by the
32 bp (2B2C2) was upregulated in hpo mutant clones (Figures
2C and 2C0), thus pinpointing the 32 bp sequence as a HRE. We
further scanned the 32 bpHREby testing a series of reporter con-
structs, each containing a dimer of HRE sequence that mutates
different sets of 5 or 6 bp across the 32 bp sequence (Figures
2A and 2D–2E0). We found that except for the first 6 nucleotides,
any 5 or 6 bp substitutions for the rest of the 32 bp sequence
resulted in inactivation of HRE activity, thus defining a 26 bp
sequence as the minimal HRE (Figures 2A and 2D–2E0).
Sd Binds to the HRE and Regulates HRE Activity
in Conjunction with Yki
Examination of the HRE revealed the existence of a CATTCCA
sequence (Figure 2A), which perfectly matches the mammalian
TEAD/TEF family transcription factor consensus binding motif
(Xiao et al., 1991; Larkin and Ordahl, 1999). Since Sd is the sole
TEAD/TEF family transcription factor in Drosophila, we tested
the possibility that Sd could bind to the HRE. Indeed, bacterially
purified Sd protein bound avidly to the HRE in a gel shift assay
(Figure 2F). This protein-DNA interaction is specific, since it
was competed away by unlabeled HRE, or HREs that carried
mutations outside the CATTCCA motif (m1–m4), but not by HREs
that mutated the CATTCCA motif (m5 and m6) (Figure 2F).
Thus, Sd binds specifically to the CATTCCA motif within the
HRE. Consistent with the competition assay, we found that la-
beled HRE or HRE mutants m1–m4, but not m5 and m6, bound
to Sd protein in the gel shift assay (see Figure S1 in the Supple-
mental Data available with this article online). Taken together,
these results reveal a direct binding between Sd and HRE andvelopmental Cell 14, 388–398, March 2008 ª2008 Elsevier Inc. 389
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withHREbybinding to sequencesoutsideof theCATTCCAmotif.
To further corroborate the function of the HRE in transcrip-
tional regulation, we conducted a cell-based transcription assay
using a luciferase reporter driven by the HRE. While neither Sd
nor Yki activated theHRE-luciferase reporter in S2R+ cells, coex-
pression of Sd and Yki substantially activated the HRE reporter
(Figure 2G). Mutation of the Sd-binding site (CATTCCA) abol-
ished the activation of the HRE-luciferase reporter by Sd-Yki
(Figure 2G). These results are consistent with a model wherein
Sd recruits Yki to the HRE and thus regulates the expression of
diap1. A prediction of this model is that the HRE should be re-
sponsive to Yki overexpression in vivo. Indeed, a reporter con-
struct that contains a single copy of the minimal 26 bp HRE
was induced by Yki overexpression in both the eye and the
wing imaginal discs (Figure S2). Thus, the diap1 HRE exhibits
widespread activity across multiple tissues.
Figure 1. Dissection of HRE in the diap1
Locus
(A) Schematic representation of the diap1 locus
and genomic DNA fragments tested for HRE activ-
ity. At the top, filled box represents the single cod-
ing exon of diap1, empty boxes represent the first
exon of alternative transcripts RA, RB, or RC, and
arrow indicates the transcription start site of tran-
script RA. Also shown are the relative positions of
the neighboring genes,Mbs andCG5895. All HRE-
containing constructs are shown in red lines.
(B–D0) Representational data from the HRE dis-
section experiment. Two images of third-instar
eye discs are shown for each construct. hpo mu-
tant cells are marked by lack of GFP (green; B,
C, and D), and lacZ expression is shown in red
(B0, C0, and D0). Representative clones are indi-
cated by arrows. (B and B0) Construct 1. Note
the similar level of lacZ expression in hpo mutant
clones compared to the surrounding wild-type
cells. (C and C0) Construct 2. Note the elevated
level of lacZ expression in hpo mutant clones.
(D and D0) Construct 2B2C. lacZ expression is
elevated in hpo mutant clones.
Unbiased Identification of Sd
as a Yki-Binding Protein
Concomitant with the ‘‘bottom-up’’ ap-
proach to identifying the DNA-binding
factor that mediates the transcriptional
output of the Hpo pathway, we also took
a ‘‘top-down’’ approach to identify this
protein by virtue of its physical associa-
tion with Yki. For this purpose, we first se-
quenced a collection of ykimutant alleles
generated by ethane methyl sulfonate
(EMS) mutagenesis, hoping to define a
region of Yki that is required for its interac-
tionwith its putativeDNA-binding partner.
Besides a nonsense mutation that trun-
cates Yki after the first WW domain
(R310X), our analysis revealed six mis-
sense mutations that disrupt Yki function (Figure 3A). While five
out of the six mutations (E271K, Y282N, P295S, G347R, and
F351I) changed evolutionarily conserved residues in the two
WW domains, the remaining mutation (P88L) changes a con-
served residue in the N-terminal region of Yki (Figure 3A). Like
theWWdomains, the sequence surrounding P88 is evolutionarily
conserved, and represents theonly extended sequence similarity
between Yki and its mammalian homolog YAP outside the WW
domains (Figure 3A). We refer to this region as the N-terminal
homology (NH) domain. Since theWWdomains of Yki are known
to bind to the Wts kinase (Huang et al., 2005), we hypothesized
that theNHdomain, which encompasses the critical P88 residue,
might mediate an aspect of Yki function other than Wts-binding,
such as the association of Yki with a cognate DNA-binding
partner.
Based on structure-function relationship derived from the
analysis of yki mutant alleles, we conducted a yeast two-hybrid
390 Developmental Cell 14, 388–398, March 2008 ª2008 Elsevier Inc.
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million cDNA clones, we isolated 7 independent cDNA clones
representing partial sequences of Sd (Figure 3B). The over-
lapping sequences of these clones define Sd region 226-440,
located C-terminal to its DNA-binding domain, as a Yki-binding
region. Consistent with our yeast two-hybrid results, Sd and
Yki coimmunoprecipitate in Drosophila S2R+ cells (Figure 3C).
Interestingly, the P88L mutation identified from our EMS screen
abolished the binding of Yki to Sdwithout affecting Yki-Wts inter-
action (Figures 3C and 3D). On the other hand, mutating critical
residues in the WW domains abolished the binding of Yki to Wts
without affecting Yki-Sd binding (Figures 3C and 3D). These re-
sults provide a molecular explanation for the YkiP88L mutation
and further strengthen the physiological significance of Sd-Yki
interaction.
Genetic Interactions between Sd and Yki
To further validate the in vivo significance of Sd-Yki binding, we
tested genetic interactions between sd and yki using both gain-
and loss-of-function experiments.
We previously showed that overexpression of yki by theGMR-
Gal4 driver (GMR > yki) leads to increased eye size (Figure 4B)
(Huang et al., 2005). On the other hand, GMR > sd eyes were
smaller than wild-type (Figure 4C), possibly due to a squelching
effect whereby overexpressed Sd titrates out endogenous Sd
cofactors and thus causes a dominant-negative effect, as previ-
ously reported in the wing (Simmonds et al., 1998) (see also Fig-
ure 4L). Strikingly, GMR > yki+sd eyes were much larger than
GMR > yki eyes (Figure 4D). Conversely, halving the dosage of
yki substantially enhanced the decrease in eye size resulting
from sd overexpression (Figure 4E), and heterozygosity for
Figure 2. Identification of aMinimal HRE for
the diap1 Gene
(A) Further dissection of 2B2C. Shown at the top is
schematic representation of sequence similarity
between D. melanogaster and D. pseudoobscura
across the 300 bp DNA sequence of 2B2C.
Note the presence of two conserved stretches,
2B2C1 (36 bp) and 2B2C2 (32 bp). The DNA se-
quences of wild-type 2B2C2 and the scanning
mutants m1–m6, as well as their HRE activity
in vivo and Sd-binding activity in vitro, are also
shown. The boxed sequence within wild-type
2B2C2 shows the CATTCCA motif.
(B–E0) Representational data from the dissection
experiment. Two images of third-instar eye discs
are shown for each construct. hpo mutant cells
are marked by lack of GFP (green; B, C, D, and
E), and lacZ expression is shown in red (B0, C0,
D0, and E0). Representative clones are indicated
by arrows. (B and B0) Construct 2B2C1. Note the
similar level of lacZ expression in hpo mutant
clones compared to the surrounding wild-type
cells. (C and C0) Construct 2B2C2. Note the ele-
vated level of lacZ expression in hpo mutant
clones. (D and D0) Construct 2B2Cm1. lacZ ex-
pression is elevated in hpo mutant clones. (E and
E0 ) Construct 2B2Cm6. lacZ expression is similar
in hpo mutant clones and the neighboring wild-
type cells.
(F) Specific binding between Sd and HRE. Biotin-
labeled HRE (2B2C2) was incubated with bac-
terially purified His-Sd protein in Electrophoretic
Mobility Shift Assays (EMSA). The DNA-protein
complex (lane 2) was effectively competed away
by 200-fold excess of unlabeled wild-type HRE
(lane 3), as well as mutants m1, m2, m3, and m4
(lanes 6 through 9), but not by unlabeled mutants
m5 and m6 (lanes 4 and 5). Note m5 and m6,
but not m1–m4, disrupt the CATTCCA motif
(Figure 2A).
(G) Sd-dependent and Yki-dependent activation
of HRE in S2R+ cells. Note that Sd or Yki alone
had little effect on the HRE-luciferase reporter,
while coexpression of Sd and Yki substantially
activated the reporter. Also note that a mutant
HRE (m6) carrying a mutation in the CATTCCA
motif (Figure 2A) could not be activated by
Sd-Yki.
Developmental Cell 14, 388–398, March 2008 ª2008 Elsevier Inc. 391
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growth phenotype driven by yki (Figure 4F). These observations
reveal a delicate interdependence between sd and yki in growth
regulation in vivo.
The dosage-sensitive genetic interaction between sd and yki
was not limited to the eye tissue. In the Drosophila wing, halving
the dosage of yki enhanced the scalloped wing phenotype of
a hypomorphic sd allele (Figures 4I and 4J). Furthermore, halving
the dosage of yki exacerbated a small wing phenotype resulting
from sd overexpression (Figures 4K–4M). The dosage-sensitive
genetic interactions between sd and yki further support the
model that Sd functions together with Yki in the Hpo growth-reg-
ulatory pathway.
sd Is Epistatic to yki in Tissue Growth
and Target Gene Expression
If Sd functions as a DNA-binding partner for Yki in mediating the
transcriptional output of the Hpo pathway, we should expect the
growth-promoting activity of yki to be dependent on sd function.
Our observation that reducing the dosage of sd dominantly
suppressed the yki-driven eye overgrowth (Figures 4B and 4F)
is consistent with such a prediction. To further test this hypoth-
esis, we used theMARCM technique (Lee and Luo, 1999) to gen-
erate sd47M mutant clones that simultaneously overexpressed
yki (referred to as sd > yki clones for simplicity). As shown pre-
viously (Huang et al., 2005), clonal overexpression of yki led to
the formation of enlarged and round-shaped clones (Figure 5A).
However, both the large size and the round shape of the yki over-
expressing cloneswere suppressed in sd> yki clones (compare
Figures 5A and 5B). In fact, the sd > yki clones were similar
in size to sd mutant clones without yki overexpression
(compare Figures 5B and 5C). Thus, sd is required for yki-in-
duced tissue growth, demonstrating that sd is genetically epi-
static to yki.
Consistent with the epistatic relationship between sd and yki
described above, we found that inactivation of sd abolished
the increase in diap1 transcription induced by yki overexpression
(Figures 5A–5B0). We also examined the protein levels of Ex, an-
other Hpo target that is induced by yki overexpression (Figures
5E and 5E0), and found that Ex levels were no longer elevated
in sd > yki clones (Figures 5F and 5F0). Thus, sd is required for
elevated target gene expression driven by yki overexpression,
further supporting an epistatic requirement for sd in yki-induced
tissue growth.
We noted that in third-instar eye imaginal discs, sd47M clones
did not show obvious growth defects compared with the sibling
+/+ twin spots (Figure 5C and Figure S3). Consistent with this ob-
servation, sd47M clones did not affect the basal level of diap1
transcription (Figures 5C and 5C0), nor did they affect Ex protein
levels (Figures 5G and 5G0) or expression of an ex-lacZ reporter
(Figure S4). Since it is unknownwhether sd47M represents a func-
tional null allele (Srivastava et al., 2004), we cannot conclude
whether sd is required for basal level expression of Hpo target
genes. Despite this uncertainty, the complete suppression of
yki-induced overgrowth and target gene overexpression by
sd47M is striking given that this mutant allele has little effect on
normal eye growth or Hpo target genes.
We have previously shown that loss of yki results in diminished
diap1 transcription (Huang et al., 2005) (Figures 5D and 5D0). We
wished to determine whether the basal expression of Ex is also
regulated in a similar yki-dependent manner. Surprisingly, we
found that the basal level of Ex was not affected in yki clones
(Figures 5H and 5H0). Thus, the basal expression of two Hpo tar-
gets, diap1 and ex, is differentially regulated in a yki-dependent
and yki-independent manner, respectively.
Figure 3. Identification of Sd as a Yki-Binding Protein
(A) Alignment of Yki (top) with the human YAP protein (bottom). Identical amino
acids are shown in black and conservative changes are shown in gray. Only
sequences of the three conserved domains are shown: the N-terminal homol-
ogy (NH) domain, the WW1 domain, and the WW2 domain. The numbers cor-
respond to amino acid residues in Yki. Also shown are the predicted amino
acid changes caused by the six missense Yki mutations isolated in the EMS
mutagenesis screen: P88L in NH; E271K, Y282N, and P295S in WW1; and
G347R and F351I in WW2.
(B) Isolation of Sd as a Yki-binding protein in unbiased yeast two-hybrid
screens. The schematic structures of Yki and Sd proteins are shown at the
top. NH, WW1, and WW2 refer to the three conserved domains of Yki protein
as in (A); TEA refers to the DNA-binding domain of Sd. Schematics of the bait
and seven independent interacting preys from the screen are also shown. Note
that the seven independent yki clones recovered from the screen differ in their
N termini but share the same C-terminal region.
(C and D) Yki associates with Sd andWts via its NH andWWdomains, respec-
tively. HA-tagged wild-type Yki or mutants carrying point mutations in their
WW (YkiWM) or NH (YkiP88L) domains were coexpressed with HSV-Sd (C) or
V5-Wts (D) in S2R+ cells. a-HA immunoprecipitates were probed with a-HSV
and a-HA (C) or a-V5 and a-HA (D). Note that Sd coimmunoprecipitates with
Yki and YkiWM, but not YkiP88L (C), and Wts coimmunoprecipitates with Yki
and YkiP88L, but not YkiWM (D).
392 Developmental Cell 14, 388–398, March 2008 ª2008 Elsevier Inc.
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actions between sd and yki In Vivo
(A–H) Dorsal views of adult heads from the indi-
cated genotypes. All images were taken under
the same magnification. (A) GMR-Gal4/+. Wild-
type control. (B) GMR-Gal4 UAS-yki/+. Overex-
pression of yki results in an increase in eye size
(compare [B] with [A]). (C) GMR-Gal4/UAS-sd.
Overexpression of sd causes a decrease in eye
size (compare [C] with [A]). (D) GMR-Gal4 UAS-
yki/UAS-sd. The eye tissue is severely overgrown
and folded. Also note that while ommatidia are
formed properly, there is a general loss of eye pig-
ment in the posterior region of the eye (arrow-
head). (E) GMR-Gal4 UAS-sd/ykiB5. Halving the
dosage of yki significantly enhanced the small
eye phenotype caused by sd overexpression
(compare [E] with [C]). (F) sd47M/+; GMR-Gal4
UAS-yki/+. Halving the dosage of sd suppressed
the large eye phenotype caused by yki overex-
pression (compare [F] with [B]). (G) GMR-Gal4/
UAS-TEAD-2. Overexpression of TEAD-2 causes
a decrease in eye size (compare [G] with [A]). (H)
GMR-Gal4 UAS-yki/UAS-TEAD-2. Note the se-
verely overgrown and folded eye tissue, and the
loss of eye pigment in the posterior region of the
eye (arrowhead).
(I–M) Adult wings from the indicated genotypes. All
images were taken under the same magnification.
Hemizygous males of sdETX4, a hypomorphic allele
of sd, show a notched wing phenotype (I), which is
enhanced by halving the dosage of yki (J). Overex-
pression of sd in the wing by vg-Gal4 causes a re-
duction in wing size (compare [L] with [K]). This
phenotype is enhanced by halving the dosage of
yki (compare [M] and [L]).Yki and Vg Function Independently
in the Wing Imaginal Disc
Thedatapresented above have focusedon the eye imaginal disc.
Given the requirement of yki for wing growth (Huang et al., 2005)
and the fact that the Sd-binding HRE of diap1 is active in thewing
(Figure S2), we presume that the Sd-Yki complex can also func-
tion in thewing.As in theeyedisc, sd47Mdidnot affect basaldiap1
transcription but completely suppressed overgrowth and in-
crease in diap1 transcription induced by yki overexpression in
the wing imaginal disc (Figure S5).
Thus, the wing blade presents a unique situation where Sd can
function in two distinct transcription factor complexes, Sd-Vg
(Simmonds et al., 1998; Halder et al., 1998) and Sd-Yki (this
study), raising the issue of how these two complexes function
with respect to each other. To investigate this question, we first
asked whether the growth defect of yki or vg clones in the wing
bladecanbe rescuedbyoverexpressionof vgor yki, respectively.
We found thatwhile yki cloneswere rarely recovered throughout
third-instar wing discs (Figure 6C), yki clones that overex-
pressed vg were readily recovered, both in the wing blade and
in the nonblade regions (Figure 6E). Conversely, while vg clones
were rarely recovered in the wing blade (Figure 6B), vg clonesDethat overexpressed yki were readily recovered (Figure 6D).
Thus, vg and yki do not display an epistatic relationship with
eachotherwith respect towing growth, but rather appear to func-
tion independently. Consistent with this observation, we found
that Hpo pathway targets diap1 and exwere induced by yki over-
expression in vg clones (Figures 6F–6G0). Conversely, Distalless
(Dll), a known target of Vg (Liu et al., 2000) (Figures 6H and 6H0),
was induced by vg overexpression in yki clones (Figures 6I
and 6I0). Thus, Vg and Yki function independent of each other to
regulate different target genes during wing development.
Functional Conservation between Sd
and Its Mammalian Homolog
We were interested in determining whether the growth-promot-
ing activity of the Sd-Yki complex is conserved in its mammalian
counterpart. Since the four mammalian TEAD/TEF family tran-
scription factors share a virtually identical DNA-binding domain
and are equally related in primary sequence to Sd, we analyzed
only one mammalian TEAD protein (TEAD-2) for simplicity.
Several lines of evidence support a functional conservation
between Sd and TEAD proteins. In the Drosophila eye, TEAD-2
overexpression caused a decrease in eye size (Figure 4G) similarvelopmental Cell 14, 388–398, March 2008 ª2008 Elsevier Inc. 393
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All panels show third-instar eye imaginal discs of the indicated genotype. Two channels are shown for each sample, one for GFP (green) and the other for Hpo
targets (red) diap1-lacZ (thj5c8) (A–D0) or Ex (E–H0). The genotype of each sample is shown in the green channel. All clones were induced at 50–54 hr after egg
deposition (AED). Representative clones are indicated by arrows.
(A and A0) yki-overexpressing clones marked positively by GFP, which showed an increase in diap1-lacZ. Also note the round shape and large size of the clones.
(B and B0) yki-overexpressing sd47M clones marked positively by GFP, which showed similar diap1-lacZ levels as the neighboring wild-type cells. Also note the
smaller size and the irregular shape of the clones as compared with clones in (A) and (A0).
(C and C0) sd47M clones marked by the lack of GFP, which showed similar diap1-lacZ levels as cells outside the clones. Note the similar size of the/ clones (no
GFP) and the +/+ twin spots (2XGFP). See Figure S3 for sd47M clones induced at an earlier time (36 hr AED), which did not show any growth disadvantage com-
pared with the +/+ twin spots.
(D and D0) yki clones marked by the lack of GFP, which showed decreased diap1-lacZ levels. Also note the smaller size of the/ clones (no GFP) than the +/+
twin spot (2XGFP).
(E and E0) yki-overexpressing clones marked positively by GFP, which showed an increase in Ex protein level.
(F and F0 ) yki-overexpressing sd47M clones marked positively by GFP, which showed similar Ex levels as cells outside the clones.
(G and G0) sd47M clones marked by the lack of GFP, which showed similar Ex level as the neighboring wild-type cells.
(H and H0) yki clones marked by the lack of GFP, which showed similar Ex levels as cells outside the clones.
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Scalloped Functions in the Hippo Signaling PathwayFigure 6. Yki and Vg Function Independently in the Wing Imaginal Disc
(A–E) Third-instar wing imaginal discs containing clones of the indicated genotype. All clones were induced at 50–54 hr AED and marked positively by GFP. The
wing blade area is outlined by dashed lines. (A)Wild-type clones. (B) vg clones. Note that vg clones were not recovered in the wing blade region. (C) yki clones.
Note that yki clones were rarely recovered throughout the whole wing. (D) vg clones overexpressing yki. Note the presence of large clones throughout the wing,
including the wing blade where vg clones are normally absent (B). (E) yki clones overexpressing vg. Note the recovery of larger clones throughout the wing
compared with yki clones without vg overexpression (C).
(F–G0) Third-instar wing discs bearing vg clones overexpressing yki, marked positively by GFP, and stained for diap1-lacZ (F and F0) or Ex protein (G and G0).
Representative clones are indicated by arrows. Note the increase in diap1-lacZ and Ex expression in these clones.
(H–I0) Third-instar wing discs containing wild-type clones overexpressing vg (H) or yki clones overexpressing vg (I), marked positively by GFP, and stained for Dll
protein. Representative clones are indicated by arrows. Note the ectopic induction of Dll expression (arrows) in both (H) and (H0), and (I) and (I0).to that caused by sd overexpression, suggesting that overex-
pressed TEAD-2 and Sd have a similar activity. Importantly, co-
expression of TEAD-2 and yki caused massive eye overgrowth
(Figure 4H) that was much stronger than that caused by yki over-
expression alone; GMR > yki+TEAD-2 eyes (Figure 4H) were
indistinguishable fromGMR > yki+sd eyes (Figure 4D). These re-
sults suggest that the growth-promoting activity of the Sd-Yki
complex is likely conserved in its mammalian counterpart.
DISCUSSION
Sd, a Missing Link in the Hpo
Growth-Regulatory Pathway
The Hpo signaling pathway has emerged as a central and highly
conserved mechanism that regulates organ size in animalsDe(Edgar, 2006; Pan, 2007; Harvey and Tapon, 2007). At the core
of this pathway is a kinase cascade that impinges on the trans-
criptional coactivator Yki to regulate the transcription of target
genes involved in cell growth, proliferation, and survival. Given
Yki’s pivotal position in the Hpo pathway, understanding the
mechanisms by which Yki regulates target gene expression
should provide important mechanistic insights that can facilitate
therapeutic manipulation of this crucial size-control pathway.
Amajor gap in our understanding of theHpo signaling pathway
concerns how Yki regulates target gene transcription. In this
study, we show that Sd represents a crucial missing link between
Yki and the regulatory DNA of Hpo pathway target genes. First,
an unbiaseddissection ofdiap1 regulatory region revealed amin-
imal Sd-binding enhancer element (HRE) that confers Hpo-re-
sponsive regulation. The HRE not only responded to Yki activityvelopmental Cell 14, 388–398, March 2008 ª2008 Elsevier Inc. 395
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transcriptional activity in cultured Drosophila cells. In a parallel
line of experiments, we identified Sd in an unbiased screen for
proteins that bind to a critical N-terminal Yki domain defined
by amissense allele, ykiP88L. The fact that thismissensemutation
disrupted binding of Yki to Sd supports the physiological rele-
vance of a Sd-Yki transcription complex in vivo. The identifica-
tion of Sd as a cognate Yki partner using two unbiased ap-
proaches, combined with the genetic interactions between sd
and yki, provide strong evidence that Sd is a critical DNA-binding
factor that mediates the transcriptional output of the Hpo signal-
ing pathway. It is worth noting that the requirement for sd in yki-
driven overgrowth is highly specific, since the same sdmutation
had no effect on overgrowth driven by the activated Ras onco-
gene (Prober and Edgar, 2002; Figure S6). The observation
that Yki, but not Sd, can be overexpressed (Huang et al., 2005)
or mutated (Dong et al., 2007) to elicit tissue overgrowth further
suggests that Sd is normally present in excess, and the activity of
the Sd-Yki complex is regulated throughmodulation of Yki activ-
ity effected by the Hpo kinase cascade.
The foundingmember of the TEAD family transcription factors,
TEAD-1/TEF-1, was initially identified based on its binding to the
GTIIC motif of the simian virus 40 (SV40) enhancer (Xiao et al.,
1991). The TEAD family transcription factors have been mostly
studied in the context of muscle-specific gene transcription (Lar-
kin and Ordahl, 1999), and their roles in cell proliferation and cell
survival are poorly understood. Our observation that TEAD-2 and
YAP have similar activity to Sd and Yki, respectively, suggests
that the growth-regulatory activity of the Sd-Yki complex is likely
conserved in the mammalian Hpo pathway. It is also worth not-
ing that besides growth regulation, the Hpo pathway has also
been implicated in controlling other biological processes such
as rhodopsin gene expression in mature photoreceptors (Mike-
ladze-Dvali et al., 2005) and dendrite morphogenesis in postmi-
totic neurons (Emoto et al., 2006). It remains to be determined
whether Yki partners with Sd or other (unknown) DNA-binding
factors in such nongrowth contexts.
Mechanism of Transcriptional Regulation
by the Hpo Signaling Pathway
Despite their elevated transcription upon inactivation of Hpo
pathway tumor suppressors or activation of the Yki oncoprotein,
it was previously unknown whether Yki regulates the known Hpo
pathway target genes directly or indirectly through intermediary
transcriptional regulators. We have taken an unbiased approach
to this question by isolating a HRE for diap1. This DNA element
provided several important insights into how Hpo signaling acti-
vity is converted into transcriptional output. First, the Sd protein
directly binds to the HRE and activates an HRE-luciferase re-
porter in cell culture in conjunctionwith Yki, supporting the notion
that Yki directly regulates the transcription of the diap1 gene.
Second, the minimal diap1 HRE contains non-Sd-binding se-
quence that is indispensable for HRE activity, suggesting that
the HRE likely binds to additional transcription factors besides
Sd in vivo. This latter characteristic is not unique to the HRE, but
is a general feature that has been observed for many signaling
pathways inDrosophila (BaroloandPosakony,2002).Forexample,
Notch-regulated enhancers contain not only binding sites for the
signal-regulated transcription factor Suppressor of Hairless, but396 Developmental Cell 14, 388–398, March 2008 ª2008 Elsevier Inalso binding sites for additional cofactors whose activity is Notch
independent (Barolo and Posakony, 2002). It will be important to
identify the factors that bind to the non-Sd sequence in the diap1
HRE, and to investigate whether such factors play a general role
in mediating the Hpo responsiveness of other target genes.
The identification of a minimal HRE makes possible several
new avenues of investigation to better understand the Hpo sig-
naling pathway. The minimal HRE revealed in this study should
facilitate a comprehensive cataloguing of Hpo pathway target
genes, many of which remain to be identified. It also provides
a useful tool for constructing reporters that can be used to
monitor the specific activity of the Hpo pathway in vivo. Further-
more, our workwill facilitate cell-based RNAi screens for compo-
nents or modulators of the Hpo pathway, as illustrated by the
successful use of pathway-specific luciferase reporters for inter-
rogating other signaling pathways (reviewed in Perrimon and
Mathey-Prevot, 2007).
An interesting and somewhat unexpected finding from our
study concerns the differential requirement of yki for the basal
expression of diap1 and ex, with the former being yki dependent
and the latter being yki independent, respectively. Thus, different
Hpo target genes, and by inference different enhancer elements
or their combinations, can respond to different threshold levels
of Yki activity. We suggest the basal expression of ex is mediated
by non-HRE sequence in the ex locus and is therefore indepen-
dent of yki. Excessive yki activity, either directly via an HRE in the
ex locus or indirectly by turning on another factor, promotes ex
transcription above the basal level. In contrast, Yki (through
Sd, non-Sd DNA-binding factors, or both), regulates the basal
level transcription of diap1. We note that the basal transcription
of diap1 is not necessarily regulated through the HRE, which was
identified by virtue of reporter expression under hyperactive Yki
activities. Indeed, we found that although the HRE is responsive
to yki overexpression (Figure S2), it is largely unresponsive to
loss of yki (Figure S7). Thus, the diap1 HRE revealed in this study
is uniquely sensitive to unrestrained Yki activity.
The exquisite sensitivity of yki-induced overgrowth to sd dos-
age suggests that Sd/TEAD could be specifically targeted to
ablate certain unwanted tissue growth, such as that caused by
aberrant Hpo signaling, with minimal effect on normal growth.
Thus, Sd/TEAD belongs to a growing list of genes that cause
‘‘non-oncogene addition’’—genes that cannot be mutated or
overexpressed to an extent that directly promotes tumorigene-
sis, but are still rate limiting to their specific signaling pathways
(Solimini et al., 2007). The requirement of such non-oncogenes
in tumor cells makes them excellent targets for the development
of new cancer therapeutics.
EXPERIMENTAL PROCEDURES
diap1 Reporter Flies
DNA fragments encompassing 12 kb in the diap1 locus were PCR-amplified
and cloned into CPLZN, an enhancer detector vector that contains the hsp70
basal promoter and lacZ reporter (Wharton and Crews, 1993). Sequence-veri-
fied constructs were introduced intoDrosophila by P element-mediated germ-
line transformation. The genomic DNA sequence tested in each construct is
summarized below (transcription start site of diap1-RA is designated as +1):
1 (5092/3), 2 (+342/+6795), 2A (+342/+2045), 2B (+2381/+4326), 2C
(+4308/+6795), 2B1 (+2381/+3210), 2B2 (+3183/+4326), 2B2A (+3183/
+3528), 2B2B (+3520/+3837), 2B2C (+3831/+4138), 2B2D (+4117/+4326),c.
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2B2C2 were introduced by making corresponding changes in complementary
oligonucleotides, which were annealed and cloned into CPLZN. Note that
2B2C1, 2B2C2, and the scanning mutations were all tested as dimers in the
CPLZN vector. A construct was also made that contains a single copy of the
26 bpminimal HRE in the CPLZN vector. At least three independent transform-
ants were analyzed for each reporter construct to eliminate potential positional
effects caused by transgene insertion sites.
S2R+ Cell Assays
S2R+ cells were propagated in Drosophila Schneider’s Medium (GIBCO) sup-
plemented with 10% FBS and antibiotics. For coimmunoprecipitation assays,
HA-Yki, HA-YkiWM, and V5-Wts constructs have been described previously
(Huang et al., 2005). HA-YkiP88L was constructed by introducing the point
mutation into HA-Yki using the QuikChange mutagenesis kit (Stratagene).
HSV-Sd was constructed in the pAc5.1/V5-HisB vector by adding an N-termi-
nal HSV epitope (QPELAPEDPED) between the first and second codons of
Sd. Tansfection and immunopreciptation were carried out as described (Wu
et al., 2003).
For luciferase assays, the HRE-luciferase reporter was constructed in two
steps. First, the hsp70 basal promoter from pUAST was cloned into pGL3-
Basic vector (Promega). Two tandem copies of the wild-type HRE sequence
(2B2C2 in Figure 2A) or mutant HRE (m6 in Figure 2A) were then cloned
upstream of the hsp70 basal promoter to construct HRE-luciferase or m6-
luciferase. The resulting plasmids were transfected in triplicates in S2R+ cells
with Sd and/or Yki-expressing pAc5.1/V5-HisB plasmids (nontagged). Lucifer-
ase assay was carried out using Dual Luciferase Assay System (Promega) and
a FLUOstar Lumiometer (BMG LabTechnologies).
Electrophoretic Mobility Shift Assays, or EMSA
Complementary oligonucleotides corresponding to the wild-type and mutant
forms of the 32 bp HRE (2B2C2 in Figure 2A) were synthesized and annealed
for use in EMSA. Biotin-labeled probes were generated using Biotin 30 End
DNA Labeling Kit (Pierce). Full-length Sd was cloned into pET-28a vector for
expression as His-Sd fusion protein in E. coli. EMSA were performed using
the LightShift Chemiluminescent EMSA Kit (Pierce) with minor modification.
Binding reactions contained 13 Binding Buffer (50 ng/ml Poly dI-dC, 5% glyc-
erol, 50 mM KCl, 2 mM MgCl, and 100 mg/ml BSA), 1.2 mg of His-Sd, and
50 fmol of biotin-labeled probe, with or without 10 pmol of competitor. After in-
cubation on ice for 30 min, protein-DNA complexes were separated on 5%
nondenaturing polyacrylamide gel.
Yeast Two-Hybrid Screens
Yeast two-hybrid screens were carried out using Stratagene’s CytoTrap sys-
tem andDrosophila cDNA library according to the manufacturer’s instructions.
The bait plasmidwas constructed using anN-terminal fragment of Yki (47-151).
Drosophila Genetics
EMS mutagenesis screens for yki mutant alleles were conducted by crossing
EMS-treated w; FRT42males en masse with w; Adv/CyO females. The result-
ing F1 w; FRT42/CyO males were individually crossed with w; ykiB5[w+]/CyO
flies, and the crosses that did not produce non-CyO F2 progenywere identified
as carrying new yki alleles on the FRT42 chromosome. Genomic DNA span-
ning the yki gene was PCR-amplified from embryos homozygous for a given
yki allele and directly sequenced to reveal their molecular lesions.
The following flies have been described previously: ykiB5,UAS-yki, andUAS-
YAP (Huang et al., 2005); UAS-sd and UAS-vg (Simmonds et al., 1998; Halder
et al., 1998); the ex-lacZ reporter exe1 (Hamaratoglu et al., 2006); and hpo42-47
and the diap1-lacZ reporter thj5c8 (Wu et al., 2003). sdETX4 is a hypomorphic vi-
able allele that affects wing only. sd47M is a strong, first-instar lethal allele. It has
a 157 bp deletion that is predicted to cause a frameshift after the DNA-binding
domain (Srivastava et al., 2004), thus removing the bulk of the Vg-binding (Sim-
monds et al., 1998) and Yki-binding (Figure 3B) region. vg83b27R is a null allele of
vg (Kim et al., 1996). UAS-TEAD-2 was constructed by cloning a full-length
mouse TEAD-2 cDNA (gift of Alex Vassilev and Melvin DePamphilis) into the
pUAST vector.
The following genotypes were used to analyze mutant clones in imaginal
discs. All clones were induced at 50–54 hr after egg deposition (AED) unlessDeotherwise indicated. For tissue staining, antibodies against Ex and Dll were
gifts from Rick Fehon and Ian Duncan, respectively.
GFP+ clones overexpressing yki (Figures 5A and 5E and Figure S5A):
UAS-GFP hs-Flp; tub-Gal80 FRT42D/FRT42D; tub-Gal4/UAS-yki thj5c8
GFP+ sd clones overexpressing yki (Figures 5B and 5F and Figure S5B):
tub-Gal80 hs-Flp FRT19A/sd47M FRT19A; UAS-GFP; tub-Gal4/UAS-yki
thj5c8
GFP+ sd clones:
tub-Gal80 hs-Flp FRT19A/sd47M FRT19A; UAS-GFP/exe1; tub-Gal4
(Figures S4A and S4B)
tub-Gal80 hs-Flp FRT19A/sd47M FRT19A; UAS-GFP; tub-Gal4/thj5c8
(Figure S5C)
GFP sd clones (Figures 5C and 5G and Figure S3):
hs-Flp; Ubi-GFP FRT19A/sd47M FRT19A
GFP yki clones (Figures 5D and 5H):
hs-Flp; FRT42D ykiB5/ FRT42D Ubi-GFP
GFP+ wild-type clones (Figure 6A):
UAS-GFP hs-Flp; tub-Gal80 FRT42D/FRT42D; tub-Gal4
GFP+ yki clones (Figure 6C):
UAS-GFP hs-Flp; tub-Gal80 FRT42D/FRT42D ykiB5; tub-Gal4
GFP+ clones overexpressing vg (Figure 6H):
UAS-GFP hs-Flp; tub-Gal80 FRT42D/FRT42D; tub-Gal4/UAS-vg
GFP+ yki clones overexpressing vg (Figures 6E and 6I):
UAS-GFP hs-Flp; tub-Gal80 FRT42D/FRT42D ykiB5; tub-Gal4/UAS-vg
GFP+ vg clones (Figure 6B):
UAS-GFP hs-Flp; tub-Gal80 FRT42D/FRT42Dvg83b27R; tub-Gal4
GFP+ vg clones overexpressing yki (Figures 6D, 6F, and 6G):
UAS-GFP hs-Flp; tub-Gal80 FRT42D/FRT42Dvg83b27R; tub-Gal4/UAS-yki
thj5c8
GFP+ clones overexpressing RasV12 (Figure S6):
tub-Gal80 hs-Flp FRT19A/ FRT19A; UAS-GFP; tub-Gal4/UAS-RasV12
GFP+ sd clones overexpressing RasV12 (Figure S6):
tub-Gal80 hs-Flp FRT19A/sd47M FRT19A; UAS-GFP; tub-Gal4/UAS-
RasV12
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